Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.

Li K, Anderson G, Viallon V, Arveux P, Kvaskoff M, Fournier A, Krogh V, Tumino R, Sánchez MJ, Ardanaz E, Chirlaque MD, Agudo A, Muller DC, Smith T, Tzoulaki I, Key TJ, Bueno-de-Mesquita B, Trichopoulou A, Bamia C, Orfanos P, Kaaks R, Hüsing A, Fortner RT, Zeleniuch-Jacquotte A, Sund M, Dahm CC, Overvad K, Aune D, Weiderpass E, Romieu I, Riboli E, Gunter MJ, Dossus L, Prentice R, Ferrari P.

Breast Cancer Res. 2018 Dec 3;20(1):147. doi: 10.1186/s13058-018-1073-0.

2.

CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation.

Honda K, Katzke VA, Hüsing A, Okaya S, Shoji H, Onidani K, Olsen A, Tjønneland A, Overvad K, Weiderpass E, Vineis P, Muller D, Tsilidis K, Palli D, Pala V, Tumino R, Naccarati A, Panico S, Aleksandrova K, Boeing H, Bueno-de-Mesquita HB, Peeters PH, Trichopoulou A, Lagiou P, Khaw KT, Wareham N, Travis RC, Merino S, Duell EJ, Rodríguez-Barranco M, Chirlaque MD, Barricarte A, Rebours V, Boutron-Ruault MC, Romana Mancini F, Brennan P, Scelo G, Manjer J, Sund M, Öhlund D, Canzian F, Kaaks R.

Int J Cancer. 2019 Apr 15;144(8):1877-1887. doi: 10.1002/ijc.31900. Epub 2018 Dec 4.

PMID:
30259989
3.

Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.

Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer, Guida F, Sun N, Bantis LE, Muller DC, Li P, Taguchi A, Dhillon D, Kundnani DL, Patel NJ, Yan Q, Byrnes G, Moons KGM, Tjønneland A, Panico S, Agnoli C, Vineis P, Palli D, Bueno-de-Mesquita B, Peeters PH, Agudo A, Huerta JM, Dorronsoro M, Barranco MR, Ardanaz E, Travis RC, Byrne KS, Boeing H, Steffen A, Kaaks R, Hüsing A, Trichopoulou A, Lagiou P, La Vecchia C, Severi G, Boutron-Ruault MC, Sandanger TM, Weiderpass E, Nøst TH, Tsilidis K, Riboli E, Grankvist K, Johansson M, Goodman GE, Feng Z, Brennan P, Johansson M, Hanash SM.

JAMA Oncol. 2018 Oct 1;4(10):e182078. doi: 10.1001/jamaoncol.2018.2078. Epub 2018 Oct 11.

PMID:
30003238
4.

Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.

Smith T, Muller DC, Moons KGM, Cross AJ, Johansson M, Ferrari P, Fagherazzi G, Peeters PHM, Severi G, Hüsing A, Kaaks R, Tjonneland A, Olsen A, Overvad K, Bonet C, Rodriguez-Barranco M, Huerta JM, Barricarte Gurrea A, Bradbury KE, Trichopoulou A, Bamia C, Orfanos P, Palli D, Pala V, Vineis P, Bueno-de-Mesquita B, Ohlsson B, Harlid S, Van Guelpen B, Skeie G, Weiderpass E, Jenab M, Murphy N, Riboli E, Gunter MJ, Aleksandrova KJ, Tzoulaki I.

Gut. 2018 Apr 3. pii: gutjnl-2017-315730. doi: 10.1136/gutjnl-2017-315730. [Epub ahead of print]

5.

Preoperative prediction of curative surgery of perihilar cholangiocarcinoma by combination of endoscopic ultrasound and computed tomography.

Kammerer S, Meister T, Wolters H, Lessing M, Hüsing A, Domagk D, Floer M, Wilms C, Schmidt H, Senninger N, Köhler G, Heinzow HS.

United European Gastroenterol J. 2018 Mar;6(2):263-271. doi: 10.1177/2050640617713651. Epub 2017 May 25.

6.

Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.

Kaaks R, Fortner RT, Hüsing A, Barrdahl M, Hopper M, Johnson T, Tjønneland A, Hansen L, Overvad K, Fournier A, Boutron-Ruault MC, Kvaskoff M, Dossus L, Johansson M, Boeing H, Trichopoulou A, Benetou V, La Vecchia C, Sieri S, Mattiello A, Palli D, Tumino R, Matullo G, Onland-Moret NC, Gram IT, Weiderpass E, Sánchez MJ, Navarro Sanchez C, Duell EJ, Ardanaz E, Larranaga N, Lundin E, Idahl A, Jirström K, Nodin B, Travis RC, Riboli E, Merritt M, Aune D, Terry K, Cramer DW, Anderson KS.

Int J Cancer. 2018 Aug 1;143(3):515-526. doi: 10.1002/ijc.31335. Epub 2018 Mar 8.

7.

Body mass index and breast cancer survival: a Mendelian randomization analysis.

Guo Q, Burgess S, Turman C, Bolla MK, Wang Q, Lush M, Abraham J, Aittomäki K, Andrulis IL, Apicella C, Arndt V, Barrdahl M, Benitez J, Berg CD, Blomqvist C, Bojesen SE, Bonanni B, Brand JS, Brenner H, Broeks A, Burwinkel B, Caldas C, Campa D, Canzian F, Chang-Claude J, Chanock SJ, Chin SF, Couch FJ, Cox A, Cross SS, Cybulski C, Czene K, Darabi H, Devilee P, Diver WR, Dunning AM, Earl HM, Eccles DM, Ekici AB, Eriksson M, Evans DG, Fasching PA, Figueroa J, Flesch-Janys D, Flyger H, Gapstur SM, Gaudet MM, Giles GG, Glendon G, Grip M, Gronwald J, Haeberle L, Haiman CA, Hall P, Hamann U, Hankinson S, Hartikainen JM, Hein A, Hiller L, Hogervorst FB, Holleczek B, Hooning MJ, Hoover RN, Humphreys K, Hunter DJ, Hüsing A, Jakubowska A, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kataja V; kConFab/AOCS Investigators, Knight JA, Koppert LB, Kosma VM, Kristensen VN, Lambrechts D, Le Marchand L, Li J, Lindblom A, Lindström S, Lissowska J, Lubinski J, Machiela MJ, Mannermaa A, Manoukian S, Margolin S, Marme F, Martens JWM, McLean C, Menéndez P, Milne RL, Marie Mulligan A, Muranen TA, Nevanlinna H, Neven P, Nielsen SF, Nordestgaard BG, Olson JE, Perez JIA, Peterlongo P, Phillips KA, Poole CJ, Pylkäs K, Radice P, Rahman N, Rüdiger T, Rudolph A, Sawyer EJ, Schumacher F, Seibold P, Seynaeve C, Shah M, Smeets A, Southey MC, Tollenaar RAEM, Tomlinson I, Tsimiklis H, Ulmer HU, Vachon C, van den Ouweland AMW, Van't Veer LJ, Wildiers H, Willett W, Winqvist R, Zamora MP, Chenevix-Trench G, Dörk T, Easton DF, García-Closas M, Kraft P, Hopper JL, Zheng W, Schmidt MK, Pharoah PDP.

Int J Epidemiol. 2017 Dec 1;46(6):1814-1822. doi: 10.1093/ije/dyx131.

8.

Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort.

Fortner RT, Schock H, Le Cornet C, Hüsing A, Vitonis AF, Johnson TS, Fichorova RN, Fashemi T, Yamamoto HS, Tjønneland A, Hansen L, Overvad K, Boutron-Ruault MC, Kvaskoff M, Severi G, Boeing H, Trichopoulou A, Papatesta EM, La Vecchia C, Palli D, Sieri S, Tumino R, Sacerdote C, Mattiello A, Onland-Moret NC, Peeters PH, Bueno-de-Mesquita HBA, Weiderpass E, Quirós JR, Duell EJ, Sánchez MJ, Navarro C, Ardanaz E, Larrañaga N, Nodin B, Jirström K, Idahl A, Lundin E, Khaw KT, Travis RC, Gunter M, Johansson M, Dossus L, Merritt MA, Riboli E, Terry KL, Cramer DW, Kaaks R.

Int J Cancer. 2018 Apr 1;142(7):1355-1360. doi: 10.1002/ijc.31164. Epub 2017 Dec 11.

9.

Selecting high-risk individuals for lung cancer screening; the use of risk prediction models vs. simplified eligibility criteria.

Kaaks R, Hüsing A, Fortner RT.

Ann Transl Med. 2017 Oct;5(20):406. doi: 10.21037/atm.2017.07.14. No abstract available.

10.

Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort.

Fortner RT, Vitonis AF, Schock H, Hüsing A, Johnson T, Fichorova RN, Fashemi T, Yamamoto HS, Tjønneland A, Hansen L, Overvad K, Boutron-Ruault MC, Kvaskoff M, Severi G, Boeing H, Trichopoulou A, Benetou V, La Vecchia C, Palli D, Sieri S, Tumino R, Matullo G, Mattiello A, Onland-Moret NC, Peeters PH, Weiderpass E, Gram IT, Jareid M, Quirós JR, Duell EJ, Sánchez MJ, Chirlaque MD, Ardanaz E, Larrañaga N, Nodin B, Brändstedt J, Idahl A, Khaw KT, Allen N, Gunter M, Johansson M, Dossus L, Merritt MA, Riboli E, Cramer DW, Kaaks R, Terry KL.

J Ovarian Res. 2017 Mar 20;10(1):20. doi: 10.1186/s13048-017-0315-6.

11.

Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort.

Hüsing A, Fortner RT, Kühn T, Overvad K, Tjønneland A, Olsen A, Boutron-Ruault MC, Severi G, Fournier A, Boeing H, Trichopoulou A, Benetou V, Orfanos P, Masala G, Pala V, Tumino R, Fasanelli F, Panico S, Bueno de Mesquita HB, Peeters PH, van Gills CH, Quirós JR, Agudo A, Sánchez MJ, Chirlaque MD, Barricarte A, Amiano P, Khaw KT, Travis RC, Dossus L, Li K, Ferrari P, Merritt MA, Tzoulaki I, Riboli E, Kaaks R.

Clin Cancer Res. 2017 Aug 1;23(15):4181-4189. doi: 10.1158/1078-0432.CCR-16-3011. Epub 2017 Feb 28.

12.

Phyto-oestrogens and colorectal cancer risk: a systematic review and dose-response meta-analysis of observational studies.

Jiang R, Botma A, Rudolph A, Hüsing A, Chang-Claude J.

Br J Nutr. 2016 Dec;116(12):2115-2128. doi: 10.1017/S0007114516004360. Epub 2017 Jan 16. Review.

PMID:
28091359
13.

Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.

Fortner RT, Hüsing A, Kühn T, Konar M, Overvad K, Tjønneland A, Hansen L, Boutron-Ruault MC, Severi G, Fournier A, Boeing H, Trichopoulou A, Benetou V, Orfanos P, Masala G, Agnoli C, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Gram IT, Gavrilyuk O, Quirós JR, Maria Huerta J, Ardanaz E, Larrañaga N, Lujan-Barroso L, Sánchez-Cantalejo E, Butt ST, Borgquist S, Idahl A, Lundin E, Khaw KT, Allen NE, Rinaldi S, Dossus L, Gunter M, Merritt MA, Tzoulaki I, Riboli E, Kaaks R.

Int J Cancer. 2017 Mar 15;140(6):1317-1323. doi: 10.1002/ijc.30560.

14.

Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation.

Thölking G, Schmidt C, Koch R, Schuette-Nuetgen K, Pabst D, Wolters H, Kabar I, Hüsing A, Pavenstädt H, Reuter S, Suwelack B.

Sci Rep. 2016 Aug 30;6:32273. doi: 10.1038/srep32273.

15.

Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report.

Seifert LL, Heinzow H, Kabar I, Christensen S, Hüsing A, Schmidt HH.

Am J Case Rep. 2016 Aug 24;17:605-10.

16.

[Ultrasound of livertransplants].

Miks A, Maschmeier M, Hüsing A, Schmidt HH, Wilms C.

Dtsch Med Wochenschr. 2016 Jul;141(13):933-9. doi: 10.1055/s-0042-103977. Epub 2016 Jun 30. Review. German.

PMID:
27359311
17.

[Long-term-management of organ transplant recipients].

Bürger C, Schmidt M, Maschmeier M, Stella J, Hüsing A, Wilms C, Schmidt HH, Kabar I.

Dtsch Med Wochenschr. 2016 Jul;141(13):927-32. doi: 10.1055/s-0042-103978. Epub 2016 Jun 30. Review. German.

PMID:
27359310
18.

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.

Terry KL, Schock H, Fortner RT, Hüsing A, Fichorova RN, Yamamoto HS, Vitonis AF, Johnson T, Overvad K, Tjønneland A, Boutron-Ruault MC, Mesrine S, Severi G, Dossus L, Rinaldi S, Boeing H, Benetou V, Lagiou P, Trichopoulou A, Krogh V, Kuhn E, Panico S, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Gram IT, Weiderpass E, Duell EJ, Sanchez MJ, Ardanaz E, Etxezarreta N, Navarro C, Idahl A, Lundin E, Jirström K, Manjer J, Wareham NJ, Khaw KT, Byrne KS, Travis RC, Gunter MJ, Merritt MA, Riboli E, Cramer DW, Kaaks R.

Clin Cancer Res. 2016 Sep 15;22(18):4664-75. doi: 10.1158/1078-0432.CCR-16-0316. Epub 2016 Apr 8.

19.

Lipids in liver transplant recipients.

Hüsing A, Kabar I, Schmidt HH.

World J Gastroenterol. 2016 Mar 28;22(12):3315-24. doi: 10.3748/wjg.v22.i12.3315. Review.

20.

Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation.

Thölking G, Siats L, Fortmann C, Koch R, Hüsing A, Cicinnati VR, Gerth HU, Wolters HH, Anthoni C, Pavenstädt H, Suwelack B, Schmidt HH, Kabar I.

Ann Transplant. 2016 Mar 22;21:167-79.

21.

Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors.

Hüsing A, Schmidt M, Beckebaum S, Cicinnati VR, Koch R, Thölking G, Stella J, Heinzow H, Schmidt HH, Kabar I.

Ann Transplant. 2015 Nov 26;20:707-13.

22.

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.

Dhayat SA, Hüsing A, Senninger N, Schmidt HH, Haier J, Wolters H, Kabar I.

PLoS One. 2015 Oct 8;10(10):e0140066. doi: 10.1371/journal.pone.0140066. eCollection 2015.

23.

[Critically ill patients with decompensated liver cirrhosis - New aspects and intensive care management].

Maschmeier M, Hüsing A, Schmidt H, Kabar I.

Dtsch Med Wochenschr. 2015 Oct;140(20):1514-6. doi: 10.1055/s-0041-105973. Epub 2015 Oct 7. German.

PMID:
26445254
24.

Interferon-Free Sofosbuvir-Based Anti-HCV Therapy After Liver Transplantation.

Seifert LL, Vorona E, Bester C, Stahl M, Hüsing A, Beckebaum S, Kabar I, Heinzow H, Schmidt HH.

Ann Transplant. 2015 Sep 22;20:561-8. doi: 10.12659/AOT.893640.

25.

Weight cycling and the risk of type 2 diabetes in the EPIC-Germany cohort.

Neamat-Allah J, Barrdahl M, Hüsing A, Katzke VA, Bachlechner U, Steffen A, Kaaks R, Schulze MB, Boeing H, Kühn T.

Diabetologia. 2015 Dec;58(12):2718-25. doi: 10.1007/s00125-015-3755-9. Epub 2015 Sep 16.

PMID:
26376796
26.

Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg.

Barth SD, Schulze JJ, Kühn T, Raschke E, Hüsing A, Johnson T, Kaaks R, Olek S.

J Natl Cancer Inst. 2015 Aug 22;107(11). pii: djv224. doi: 10.1093/jnci/djv224. Print 2015 Nov.

PMID:
26298011
27.

Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine.

Hüsing A, Kabar I, Schmidt HH, Heinzow HS.

Int J Mol Sci. 2015 Aug 5;16(8):18033-53. doi: 10.3390/ijms160818033. Review.

28.

Complications after endoscopic sphincterotomy in liver transplant recipients: A retrospective single-centre study.

Hüsing A, Cicinnati VR, Maschmeier M, Schmidt HH, Wolters HH, Beckebaum S, Kabar I.

Arab J Gastroenterol. 2015 Jun;16(2):46-9. doi: 10.1016/j.ajg.2015.04.001. Epub 2015 Jul 9.

PMID:
26166543
29.

Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.

Li K, Hüsing A, Sookthai D, Bergmann M, Boeing H, Becker N, Kaaks R.

Cancer Prev Res (Phila). 2015 Sep;8(9):777-85. doi: 10.1158/1940-6207.CAPR-14-0424. Epub 2015 Jun 15.

30.

An epidemiological model for prediction of endometrial cancer risk in Europe.

Hüsing A, Dossus L, Ferrari P, Tjønneland A, Hansen L, Fagherazzi G, Baglietto L, Schock H, Chang-Claude J, Boeing H, Steffen A, Trichopoulou A, Bamia C, Katsoulis M, Krogh V, Palli D, Panico S, Onland-Moret NC, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Gram IT, Ardanaz E, Obón-Santacana M, Navarro C, Sánchez-Cantalejo E, Etxezarreta N, Allen NE, Khaw KT, Wareham N, Rinaldi S, Romieu I, Merritt MA, Gunter M, Riboli E, Kaaks R.

Eur J Epidemiol. 2016 Jan;31(1):51-60. doi: 10.1007/s10654-015-0030-9. Epub 2015 May 13.

31.

Analysis of bile colonization and intestinal flora may improve management in liver transplant recipients undergoing ERCP.

Kabar I, Hüsing A, Cicinnati VR, Heitschmidt L, Beckebaum S, Thölking G, Schmidt HH, Karch H, Kipp F.

Ann Transplant. 2015 May 4;20:249-55. doi: 10.12659/AOT.893549.

32.

Common germline polymorphisms associated with breast cancer-specific survival.

Pirie A, Guo Q, Kraft P, Canisius S, Eccles DM, Rahman N, Nevanlinna H, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, Dunning AM, Shah M, Czene K, Darabi H, Eriksson M, Lambrechts D, Weltens C, Leunen K, van Ongeval C, Nordestgaard BG, Nielsen SF, Flyger H, Rudolph A, Seibold P, Flesch-Janys D, Blomqvist C, Aittomäki K, Fagerholm R, Muranen TA, Olsen JE, Hallberg E, Vachon C, Knight JA, Glendon G, Mulligan AM, Broeks A, Cornelissen S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Cross SS, Reed MW, Giles GG, Milne RL, McLean C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning MJ, Hollestelle A, Martens JW, van den Ouweland AM, Marme F, Schneeweiss A, Yang R, Burwinkel B, Figueroa J, Chanock SJ, Lissowska J, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Brenner H, Butterbach K, Holleczek B, Kataja V, Kosma VM, Hartikainen JM, Li J, Brand JS, Humphreys K, Devilee P, Tollenaar RA, Seynaeve C, Radice P, Peterlongo P, Manoukian S, Ficarazzi F, Beckmann MW, Hein A, Ekici AB, Balleine R, Phillips KA; kConFab Investigators, Benitez J, Zamora MP, Perez JI, Menéndez P, Jakubowska A, Lubinski J, Gronwald J, Durda K, Hamann U, Kabisch M, Ulmer HU, Rüdiger T, Margolin S, Kristensen V, Nord S; NBCS Investigators, Evans DG, Abraham J, Earl H, Poole CJ, Hiller L, Dunn JA, Bowden S, Yang R, Campa D, Diver WR, Gapstur SM, Gaudet MM, Hankinson S, Hoover RN, Hüsing A, Kaaks R, Machiela MJ, Willett W, Barrdahl M, Canzian F, Chin SF, Caldas C, Hunter DJ, Lindstrom S, Garcia-Closas M, Couch FJ, Chenevix-Trench G, Mannermaa A, Andrulis IL, Hall P, Chang-Claude J, Easton DF, Bojesen SE, Cox A, Fasching PA, Pharoah PD, Schmidt MK.

Breast Cancer Res. 2015 Apr 22;17:58. doi: 10.1186/s13058-015-0570-7.

33.

Identification of novel genetic markers of breast cancer survival.

Guo Q, Schmidt MK, Kraft P, Canisius S, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, Kar S, Beesley J, Dunning AM, Shah M, Czene K, Darabi H, Eriksson M, Lambrechts D, Weltens C, Leunen K, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Blomqvist C, Aittomäki K, Fagerholm R, Muranen TA, Couch FJ, Olson JE, Vachon C, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Broeks A, Hogervorst FB, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Cox A, Cross SS, Reed MW, Giles GG, Milne RL, McLean C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning MJ, Hollestelle A, Martens JW, van den Ouweland AM, Marme F, Schneeweiss A, Yang R, Burwinkel B, Figueroa J, Chanock SJ, Lissowska J, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Brenner H, Dieffenbach AK, Arndt V, Holleczek B, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Li J, Brand JS, Humphreys K, Devilee P, Tollenaar RA, Seynaeve C, Radice P, Peterlongo P, Bonanni B, Mariani P, Fasching PA, Beckmann MW, Hein A, Ekici AB, Chenevix-Trench G, Balleine R; kConFab Investigators, Phillips KA, Benitez J, Zamora MP, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Hamann U, Kabisch M, Ulmer HU, Rüdiger T, Margolin S, Kristensen V, Nord S, Evans DG, Abraham JE, Earl HM, Hiller L, Dunn JA, Bowden S, Berg C, Campa D, Diver WR, Gapstur SM, Gaudet MM, Hankinson SE, Hoover RN, Hüsing A, Kaaks R, Machiela MJ, Willett W, Barrdahl M, Canzian F, Chin SF, Caldas C, Hunter DJ, Lindstrom S, García-Closas M, Hall P, Easton DF, Eccles DM, Rahman N, Nevanlinna H, Pharoah PD.

J Natl Cancer Inst. 2015 Apr 18;107(5). pii: djv081. doi: 10.1093/jnci/djv081. Print 2015 May.

34.

An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.

Li K, Hüsing A, Fortner RT, Tjønneland A, Hansen L, Dossus L, Chang-Claude J, Bergmann M, Steffen A, Bamia C, Trichopoulos D, Trichopoulou A, Palli D, Mattiello A, Agnoli C, Tumino R, Onland-Moret NC, Peeters PH, Bueno-de-Mesquita HB, Gram IT, Weiderpass E, Sánchez-Cantalejo E, Chirlaque MD, Duell EJ, Ardanaz E, Idahl A, Lundin E, Khaw KT, Travis RC, Merritt MA, Gunter MJ, Riboli E, Ferrari P, Terry K, Cramer D, Kaaks R.

Br J Cancer. 2015 Mar 31;112(7):1257-65. doi: 10.1038/bjc.2015.22.

35.

Paclitaxel-eluting balloon dilation of biliary anastomotic stricture after liver transplantation.

Hüsing A, Reinecke H, Cicinnati VR, Beckebaum S, Wilms C, Schmidt HH, Kabar I.

World J Gastroenterol. 2015 Jan 21;21(3):977-81. doi: 10.3748/wjg.v21.i3.977.

36.

The tacrolimus metabolism rate influences renal function after kidney transplantation.

Thölking G, Fortmann C, Koch R, Gerth HU, Pabst D, Pavenstädt H, Kabar I, Hüsing A, Wolters H, Reuter S, Suwelack B.

PLoS One. 2014 Oct 23;9(10):e111128. doi: 10.1371/journal.pone.0111128. eCollection 2014.

37.

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.

Joshi AD, Lindström S, Hüsing A, Barrdahl M, VanderWeele TJ, Campa D, Canzian F, Gaudet MM, Figueroa JD, Baglietto L, Berg CD, Buring JE, Chanock SJ, Chirlaque MD, Diver WR, Dossus L, Giles GG, Haiman CA, Hankinson SE, Henderson BE, Hoover RN, Hunter DJ, Isaacs C, Kaaks R, Kolonel LN, Krogh V, Le Marchand L, Lee IM, Lund E, McCarty CA, Overvad K, Peeters PH, Riboli E, Schumacher F, Severi G, Stram DO, Sund M, Thun MJ, Travis RC, Trichopoulos D, Willett WC, Zhang S, Ziegler RG, Kraft P; Breast and Prostate Cancer Cohort Consortium (BPC3).

Am J Epidemiol. 2014 Nov 15;180(10):1018-27. doi: 10.1093/aje/kwu214. Epub 2014 Sep 25.

38.

Endoscopic ultrasound: valuable tool for diagnosis of biliary complications in liver transplant recipients?

Hüsing A, Cicinnati VR, Beckebaum S, Wilms C, Schmidt HH, Kabar I.

Surg Endosc. 2015 Jun;29(6):1433-8. doi: 10.1007/s00464-014-3820-3. Epub 2014 Aug 27.

PMID:
25159653
39.

Can the use of blood-based biomarkers in addition to anthropometric indices substantially improve the prediction of visceral fat volume as measured by magnetic resonance imaging?

Neamat-Allah J, Johnson T, Nabers D, Hüsing A, Teucher B, Katzke V, Delorme S, Kaaks R, Kühn T.

Eur J Nutr. 2015 Aug;54(5):701-8. doi: 10.1007/s00394-014-0748-2. Epub 2014 Aug 7.

PMID:
25098781
40.

Lifestyle risk factors and residual life expectancy at age 40: a German cohort study.

Li K, Hüsing A, Kaaks R.

BMC Med. 2014 Apr 7;12:59. doi: 10.1186/1741-7015-12-59.

41.

Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging--a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts.

Neamat-Allah J, Wald D, Hüsing A, Teucher B, Wendt A, Delorme S, Dinkel J, Vigl M, Bergmann MM, Feller S, Hierholzer J, Boeing H, Kaaks R.

PLoS One. 2014 Mar 13;9(3):e91586. doi: 10.1371/journal.pone.0091586. eCollection 2014.

42.

Primary preventive potential of major lifestyle risk factors for acute myocardial infarction in men: an analysis of the EPIC-Heidelberg cohort.

Li K, Monni S, Hüsing A, Wendt A, Kneisel J, Groß ML, Kaaks R.

Eur J Epidemiol. 2014 Jan;29(1):27-34. doi: 10.1007/s10654-013-9872-1. Epub 2014 Jan 8.

PMID:
24399287
43.

Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?

Lukanova A, Becker S, Hüsing A, Schock H, Fedirko V, Trepo E, Trichopoulou A, Bamia C, Lagiou P, Benetou V, Trichopoulos D, Nöthlings U, Tjønneland A, Overvad K, Dossus L, Teucher B, Boeing H, Aleksandrova K, Palli D, Pala V, Panico S, Tumino R, Ricceri F, Bueno-de-Mesquita HB, Siersema PD, Peeters PH, Quiros JR, Duell EJ, Molina-Montes E, Chirlaque MD, Gurrea AB, Dorronsoro M, Lindkvist B, Johansen D, Werner M, Sund M, Khaw KT, Wareham N, Key TJ, Travis RC, Rinaldi S, Romieu I, Gunter MJ, Riboli E, Jenab M, Kaaks R.

Int J Cancer. 2014 Jan 1;134(1):164-73. doi: 10.1002/ijc.28342. Epub 2013 Aug 2.

44.

Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Hendrickson SJ, Lindström S, Eliassen AH, Rosner BA, Chen C, Barrdahl M, Brinton L, Buring J, Canzian F, Chanock S, Clavel-Chapelon F, Figueroa JD, Gapstur SM, Garcia-Closas M, Gaudet MM, Haiman CA, Hazra A, Henderson B, Hoover R, Hüsing A, Johansson M, Kaaks R, Khaw KT, Kolonel LN, Le Marchand L, Lissowska J, Lund E, McCullough ML, Peplonska B, Riboli E, Sacerdote C, Sánchez MJ, Tjønneland A, Trichopoulos D, van Gils CH, Yeager M, Kraft P, Hunter DJ, Ziegler RG, Willett WC.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):927-36. doi: 10.1158/1055-9965.EPI-13-0017. Epub 2013 Mar 20.

45.

Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status.

Hüsing A, Canzian F, Beckmann L, Garcia-Closas M, Diver WR, Thun MJ, Berg CD, Hoover RN, Ziegler RG, Figueroa JD, Isaacs C, Olsen A, Viallon V, Boeing H, Masala G, Trichopoulos D, Peeters PH, Lund E, Ardanaz E, Khaw KT, Lenner P, Kolonel LN, Stram DO, Le Marchand L, McCarty CA, Buring JE, Lee IM, Zhang S, Lindström S, Hankinson SE, Riboli E, Hunter DJ, Henderson BE, Chanock SJ, Haiman CA, Kraft P, Kaaks R; BPC3.

J Med Genet. 2012 Sep;49(9):601-8. doi: 10.1136/jmedgenet-2011-100716.

46.

Serum enterolactone and prognosis of postmenopausal breast cancer.

Buck K, Vrieling A, Zaineddin AK, Becker S, Hüsing A, Kaaks R, Linseisen J, Flesch-Janys D, Chang-Claude J.

J Clin Oncol. 2011 Oct 1;29(28):3730-8. doi: 10.1200/JCO.2011.34.6478. Epub 2011 Sep 6.

PMID:
21900115
47.

Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.

Campa D, Hüsing A, Dostal L, Stein A, Drogan D, Boeing H, Tjønneland A, Roswall N, Østergaard JN, Overvad K, Rodríguez L, Bonet C, Sánchez MJ, Larrañaga N, Huerta JM, Ardanaz E, Khaw KT, Wareham N, Travis RC, Allen NE, Trichopoulou A, Zylis D, Karapetyan T, Palli D, Sieri S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Lenner P, Johansson M, Jenab M, Cox D, Siddiq A, Kaaks R, Canzian F.

Oncol Rep. 2011 Oct;26(4):979-86. doi: 10.3892/or.2011.1359. Epub 2011 Jun 24.

PMID:
21725602
48.

Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.

Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Husing A, Kaaks R, Koskela P, Grankvist K, Pukkala E, Zeleniuch-Jacquotte A, Lehtinen M, Toniolo P.

Int J Cancer. 2012 Feb 15;130(4):910-20. doi: 10.1002/ijc.26070. Epub 2011 May 9.

49.

Association of serum 25-hydroxyvitamin D (25-OHD) concentrations with maternal sex steroids and IGF-1 hormones during pregnancy.

Toriola AT, Surcel HM, Husing A, Grankvist K, Lakso HA, Schock H, Lundin E, Lehtinen M, Lukanova A.

Cancer Causes Control. 2011 Jun;22(6):925-8. doi: 10.1007/s10552-011-9752-5. Epub 2011 Mar 9.

50.

Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).

Campa D, Hüsing A, Stein A, Dostal L, Boeing H, Pischon T, Tjønneland A, Roswall N, Overvad K, Østergaard JN, Rodríguez L, Sala N, Sánchez MJ, Larrañaga N, Huerta JM, Barricarte A, Khaw KT, Wareham N, Travis RC, Allen NE, Lagiou P, Trichopoulou A, Trichopoulos D, Palli D, Sieri S, Tumino R, Sacerdote C, van Kranen H, Bueno-de-Mesquita HB, Hallmans G, Johansson M, Romieu I, Jenab M, Cox DG, Siddiq A, Riboli E, Canzian F, Kaaks R.

PLoS One. 2011 Feb 23;6(2):e16914. doi: 10.1371/journal.pone.0016914.

Supplemental Content

Loading ...
Support Center